| Autor: |
Zavalishin IA, Gusev EI, Iakhno NN, Skoromets AA, Boĭko AN, Demina TL, Burlutskiĭ A P, Beĭn BN, Sholomov II, Pereserdova AV, Stoĭda NI, Zakharova MN, Adarcheva LS, Niiazbekova AS, Askarova LSh, Oleĭnikov VG, Rebrova OIu, Shmidt TE, Davydovskaia MV, Totolian NA, Beskhmel'nitsina IA, Bragina OV, Ponomareva GL, Durseneva OM, Voronchikhina SA, Volkova LI, Turova EL, Streknev AG |
| Jazyk: |
ruština |
| Zdroj: |
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova [Zh Nevrol Psikhiatr Im S S Korsakova] 2003 (Spec No 2), pp. 73-8. |
| Abstrakt: |
The results of multicenter study of Rebif 22 micrograms in Russia have been reported. 167 multiple sclerosis patients have received Rebif 22 micrograms three times a week for 1 year. This study provides evidence for reduction of the relapse rate in patients with relapsing/remitting and secondary progressive multiple sclerosis. The tendency to the decrease of the severity of relapses, less need for steroid use and the decrease of EDSS score in patients with relapsing/remitting multiple sclerosis have been shown. In general Rebif 22 micrograms was tolerated well. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
